Federal
Register Notices > Notices
of Registration - 2002 > Sigma Aldrich
Research Biochemicals
[Federal Register: January 8, 2002 (Volume 67,
Number 5)]
[Notices]
[Page 920-921]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08ja02-111]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice
of Registration
By notice dated August 9, 2001, and published in
the Federal Register on August 10, 2001, (66 FR 42240), Sigma Aldrich
Research Biochemicals, Inc., Attn: Richard Milius, 1-3 Strathmore Road,
Natick, Massachusetts 01760, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk manufacturer
of the basic classes of controlled substances listed below:
Drug |
Schedule |
Cathinone (1235) |
I |
Methcathinone
(1237) |
I |
Aminorex (1585) |
I |
Alpha-Ethyltryptamine
(7249) |
I |
Lysergic acid
diethylamide (7315) |
I |
Tetrahydrocannabinols
(7370) |
I |
4-Bromo-2,
5-dimethoxyamphetamine (7391) |
I |
4-Bromo-2,
5-dimethoxyphenethylamine (7392) |
I |
2,
5-Dimethoxyamphetamine (7396) |
I |
3,
4-Methylenedioxyamphetamine (7400) |
I |
N-Hydroxy-3,
4-methylenedioxyamphetamine (7402) |
I |
3,
4-Methylenedioxy-N-ethylamphetamine (7404) |
I |
3,
4-Methylenedioxymethamphetamine (7405) |
I |
1-[(2-Thienyl)
cyclohexyl]piperidine (7470) |
I |
Heroin (9200) |
I |
Normorphine (9313) |
I |
Amphetamine (1100) |
II |
Methamphetamine
(1105) |
II |
Phenylcyclohexylamine
(7460) |
II |
Phencyclidine
(7471) |
II |
Cocaine (9041) |
II |
Codeine (9050) |
II |
Diprenorphine
(9058) |
II |
Benzoylecogonine
(9180) |
II |
Levomethorphan
(9210) |
II |
Levorphanol (9220) |
II |
Meperidine (9230) |
II |
Metazocine (9240) |
II |
Methadone (9250) |
II |
Morphine (9300) |
II |
Thebaine (9333) |
II |
Canfentanil (9773) |
II |
Levo-alphacetylmethadol
(LAAM) (9648) |
II |
Fentanyl (9801) |
II |
The firm plans to manufacture the listed
controlled substances for laboratory reference standards and
neurochemicals.
DEA has considered the factors in Title 21, United
States Code, Section 823(a) and determined that the registration of
Sigma Aldrich Research Biochemicals, Inc. to manufacture the listed
controlled substances is consistent with the public interest at this
time. DEA has investigated Sigma Aldrich Research Biochemicals, Inc. on
a regular basis to ensure that the company's continued registration is
consistent with the public interest.
[[Page 921]]
These investigations have included inspection and
testing of the company's physical security systems, audits of the
company's records, verification of the company's compliance with state
and local laws, and a review of the company's background and history.
Therefore, pursuant to 21
U.S.C. 823 and 28 CFR 0.100 and 0.104, the
Deputy Assistant Administrator Office of Diversion Control, hereby
orders that the application submitted by the above firm for registration
as a bulk manufacturer of the basic classes of controlled substances
listed above is granted.
Dated: December 28, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 02 - 415 Filed 1-7- 02 ; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|